Prism Medico and Pharmacy: Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

Dear Sir/Madam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 13th February 2026) which commenced at 01:00 P.M. and concluded at 05:30 P.M. have inter alia approved the following:? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 31st December 2025 along with the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.Thanking You.